List
The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.
-
Record 1 TO 1000
-
Record 1001 TO 1044
-
Client tools for neuroscience databases
SBC: BRUXTON CORPORATION Topic: N/AN/A
SBIR Phase I 2003 Department of Health and Human Services -
Client tools for neuroscience databases
SBC: BRUXTON CORPORATION Topic: N/AN/A
SBIR Phase II 2003 Department of Health and Human Services -
Internet-based Alzheimer's Caregiver Support System
SBC: Caregiver Technologies, Inc. Topic: N/ADESCRIPTION (provided by investigator): The Iong-term objective of Small Business Innovative Research Phase I is to develop an Internet based Alzheimer's Caregiver Support System (iACSS). The iACSS would enable care to be provided remotely to individuals with Alzheimer's disease over the Internet. iACSS would feature a videoconferencing capability to communicate and monitor the Alzheimer's patien ...
SBIR Phase I 2003 Department of Health and Human Services -
Augmenting innate and vaccine immune response with der-G
SBC: CEL-SCI CORPORATION Topic: N/ADESCRIPTION (provided by applicant): Concerns regarding the United States' vulnerability to a terrorist attack with smallpox have stimulated development of new vaccines, prophylactics and therapeutics. However, a new and successful smallpox vaccine intervention program, or one to treat exposed individual requires not only an effective vaccine, but also agents to treat the complications arising fr ...
SBIR Phase I 2003 Department of Health and Human Services -
derG Immunostimulant Prevention/Treatment of HSV Disease
SBC: CEL-SCI CORPORATION Topic: N/ADESCRIPTION (provided by the applicant): The goal of this program is to develop derG as a therapeutic and/or prophylactic agent for HSV infections. DerG is a small peptide shown in preliminary experiments to elicit anti-viral and anti-parasitic (malarial) responses, and adjuvant activity. Based upon its structure, derG should bind to CD4 molecules. Its broad spectrum of activity suggests that it ...
SBIR Phase I 2003 Department of Health and Human Services -
Peptide Vaccine for Experimental Autoimmune Myocarditis
SBC: CEL-SCI CORPORATION Topic: N/ADESCRIPTION (provided by the applicant): In A/J Mice Experimental Autoimmune Myocarditis (EAM) can be induced by infection with coxsackie virus B 3 or by immunization with murine or porcine cardiac myosin or a cardiogenic peptide from the murine cardiac myosin (My-l). In all these three cases the mice develop autoantibodies to cardiac myosin, and the disease is characterized by a Th2 phenotype. P ...
SBIR Phase I 2003 Department of Health and Human Services -
The Sentinel Event Tracking Network(SETNET)System
SBC: CEREPLEX Topic: N/ADESCRIPTION (provided by applicant): Hospital-acquired infections, antimicrobial use, and antimicrobial resistance are complex and inter-related problems, responsible for high health and financial costs, that every hospital faces. Cereplex, Inc. is developing its internet-based Sentinel Event Tracking Network (SETNET) application to fulfill hospitals' unmet needs in this area. In Phase 1 SETNET ...
SBIR Phase II 2003 Department of Health and Human Services -
N/A
SBC: CIRCUMPLEX COMPANY Topic: N/AN/A
SBIR Phase I 2003 Department of Health and Human Services -
N/A
SBC: CIRCUMPLEX COMPANY Topic: N/AN/A
SBIR Phase II 2003 Department of Health and Human Services -
Sleep Research with Digital Video Technologies
SBC: Clever Systems, Inc. Topic: N/ADESCRIPTION (provided by applicant): The Mouse provides an excellent genetic model for the study of sleep/wake regulation, sleep. Homeostasis and the interaction between sleep and circadian processes. Study of sleep states in mice may ultimately provide insight into the control of sleep in humans. A complete phenotypic description of sleep in mouse strains is necessary for the genetic analysis of ...
SBIR Phase I 2003 Department of Health and Human Services
